Polyrizon Ltd. Ordinary Shares (PLRZ) Stock Price
PLRZStock
$10.90+65.12%52W
Market Cap$22.72M
P/E—
PEG Ratio—
Div yield—
Beta0.56
PLRZ Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-34.54%
Price vs S&P 500 (4W)-8.03%
VGM Score44.36
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PLRZPolyrizon Ltd. Ordinary Shares | — | — | C | $10.90 |
| SYKStryker Corporation | C | B | C | $330.59 |
| MMM3M Company | C | D | B | $179.37 |
| BSXBoston Scientific Corp. | C | B | D | $49.86 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.78 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.64 |
| RMDResMed Inc. | C | B | C | $236.59 |
| DXCMDexCom, Inc. | D | B | B | $89.16 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $348.48 |
| SOLVSolventum Corporation | C | C | B | $91.61 |
| BAXBaxter International Inc. | B | D | B | $26.29 |
About Polyrizon Ltd. Ordinary Shares
Polyrizon Ltd is a clinical-stage biotech company developing nasal gel treatments designed to provide preventative protection against viruses including COVID-19 variants, influenza, and allergens. The company's proprietary platforms—Capture & Contain and Trap & Target—deliver broad-spectrum respiratory pathogen defense.